Status:
COMPLETED
Relationship of pAKT to Survival in Patients With Node-Positive Breast Cancer
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
All Genders
Brief Summary
This study will examine the relationship of a protein called pAKT to survival of breast cancer patients with one or more positive axillary lymph nodes. Akt plays a role in cell survival, tumor formati...
Detailed Description
Taxanes (paclitaxel and docetaxel) have emerged as the most powerful chemotherapeutics in breast cancer over the past decades. The B-28 clinical trial from the National Surgical Adjuvant Breast and Bo...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- The NSABP B-28 trial enrolled women from 1995 to 1998 with operable breast cancer with pathologically positive axillary lymph nodes.
Exclusion
Key Trial Info
Start Date :
January 13 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 14 2010
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT00965276
Start Date
January 13 2004
End Date
December 14 2010
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892